IFP Advisors’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,750
| Closed | -$498K | – | 3193 |
|
|
2020
Q3 | $491K | Sell |
5,750
-1,395
| -20% | -$70.5K | 0.03% | 435 |
|
|
2020
Q2 | $242K | Buy |
7,145
+1,197
| +20% | +$35K | 0.02% | 601 |
|
|
2020
Q1 | $80K | Buy |
5,948
+126
| +2% | +$2.12K | 0.01% | 932 |
|
|
2019
Q4 | $125K | Buy |
5,822
+1,639
| +39% | +$28.9K | 0.01% | 836 |
|
|
2019
Q3 | $61K | Buy |
+4,183
| New | +$61.5K | ﹤0.01% | 1280 |
|
|
2019
Q1 | – | Sell |
-1,507
| Closed | -$23K | – | 3751 |
|
|
2018
Q4 | $23K | Sell |
1,507
-70,457
| -98% | -$1.4M | ﹤0.01% | 2061 |
|
|
2018
Q3 | $1.5M | Sell |
71,964
-11,270
| -14% | -$267K | 0.06% | 329 |
|
|
2018
Q2 | $1.97M | Sell |
83,234
-24,732
| -23% | -$497K | 0.08% | 251 |
|
|
2018
Q1 | $1.75M | Hold |
107,966
| – | – | 0.08% | 255 |
|
|
2017
Q4 | $1.75M | Sell |
107,966
-19,800
| -15% | -$234K | 0.08% | 256 |
|
|
2017
Q3 | $1.79M | Sell |
127,766
-10,368
| -8% | -$103K | 0.07% | 289 |
|
|
2017
Q2 | $1.22M | Sell |
138,134
-15,100
| -10% | -$106K | 0.05% | 373 |
|
|
2017
Q1 | $991K | Sell |
153,234
-9,783
| -6% | -$49.6K | 0.04% | 431 |
|
|
2016
Q4 | $598K | Hold |
163,017
| – | – | 0.03% | 548 |
|
|
2016
Q3 | $530K | Hold |
163,017
| – | – | 0.03% | 545 |
|
|
2016
Q2 | $378K | Buy |
+163,017
| New | +$545K | 0.02% | 657 |
|
|
2016
Q1 | – | Sell |
-198,517
| Closed | -$609K | – | 3741 |
|
|
2015
Q4 | $609K | Buy |
+198,517
| New | +$554K | 0.04% | 440 |
|
IFP Advisors's IMMU Position: Q4 2020 in Review
IFP Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 5,750 shares — an estimated $498K sold.
IFP Advisors first reported a position in IMMU in Q4 2015 and held it in 17 quarters. The position peaked at $1.97M in Q2 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- IFP Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- IFP Advisors sold 5,750 Immunomedics Inc shares in Q4 2020, an estimated $498K.
- IFP Advisors first reported a position in Immunomedics Inc in Q4 2015 and held it in 17 quarters.
- IFP Advisors's Immunomedics Inc position peaked at $1.97M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on IFP Advisors's 13F filing for Q4 2020, filed 25 Jan 2021.